Stanford University School of Medicine
Contact: Director Rhonda Pisk
291 Campus Drive
Tel: (650) 723-4000
8 articles with Stanford University School of Medicine
Positive Data From The Remetinostat Phase II Study in Basal Cell Carcinoma Presented at SID Annual meeting
Medivir AB announces that positive data from the investigator-initiated study evaluating the effects of remetinostat in basal cell carcinoma patients has been presented at the 2019 Society for Investigative Dermatology annual meeting in Chicago, USA.
Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.
BioSpace recently surveyed readers, asking to nominate people they view as “influencers” in the biopharma industry. BioSpace is happy to profile Tonja Green, Program Director of the Master of Science program at San Jose State University in Medical Product Development Management.
Research teams from Salk Institute for Biological Studies, Stanford University, University Hospitals Cleveland Medical Center selected to study healthy brain aging, better treatments for neurodegenerative diseases
Today, the American Heart Association, the world's leading voluntary organization focused on heart and brain health, and The Paul G. Allen Frontiers Group, a division of the Allen Institute, announced awardees of the American Heart Association-Allen Initiative in Brain Health and Cognitive Impairment, a new collaborative funding initiative launched earlier this year.
Examples of new syndromes include hypotonia, ataxia, and delayed development syndrome (HADDS) and Sashi-Pena syndrome (SHAPNS).
A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of C...
7/12/2018A*STAR’s Institute of Molecular & Cell Biology (IMCB) in Singapore, along with the Mayo Clinic, identified a key epigenetic protein called H3.3 that helps convert skin cells into other types of cells via cellular reprogramming.
New research by Stanford Medicine, conducted by The Harris Poll, has found that American physicians want substantial improvements in the way electronic health records (EHRs) work.
– LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG), announced today that it has entered into an agreement with the Stanford University School of Medicine.